Patent ID: 11903721
Assignee: nan
Field: Control (Instruments)
Classification: CPC G  A | IPC A

Claim 2:
3. A method of treating a subject having mild cognitive impairment (MCI) or dementia by one or more digital therapeutics, the method comprising:
providing one or more first digital instructions to a first user who is a subject to MCI or dementia treatment, based on at least part of a plurality of digital therapeutic modules configured to regulate one or more neurohumoral factors to treat MCI or dementia, each of the plurality of digital therapeutic modules comprising one or more first digital instructions for the first user to follow;
collecting the first user's execution outcomes of the one or more first digital instructions using a sensor, wherein the one or more neurohumoral factors comprises at least one of sex steroid hormone, insulin-like growth factor-2 (IGF-2), β-catenin in Wnt signaling, Bcl-2—associated athanogene 1 (BAG1), cAMP response element-binding protein (CREB), inflammation factors, corticosteroids, or neurohormones; and
providing one or more second digital instructions to regulate the one or more neurohumoral factors to treat the MCI or the dementia based on the first user's execution outcomes of the one or more first digital instructions.